ArticleBreast cancer (Tokyo, Japan)2024
Number of lines of previous chemotherapy regimen might affect the oucome of sacituzumab govitecan in metastatic triple-negative breast cancer patients.
Kadri AltundagPubMed ↗Publisher ↗
No numbers read from the abstract.